Cyanotech Corporation operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Cyanotech with three other
pharmaceutical manufacturers in North America:
C21 Investments Inc
sales of 49.93 million Canadian Dollars [US$39.13 million]
of which 56%
was Herbal products), and
Supreme Cannabis Company Inc
based in CANADA
(39.75 million Canadian Dollars [US$31.15 million]
During the year ended March of 2020, sales at
Cyanotech were $31.90 million.
increase of 5.6%
versus 2019, when the company's sales were $30.20 million.
Despite this increase, sales are still
below the level achieved in 2018, when Cyanotech
reported sales of $34.12 million.
The sales level in 2020 was fairly close to the level five years ago: in 2015, Cyanotech had sales
of $33.81 million.